Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/article/10.1007/s11912-018-0710-1/fulltext.html
Reference47 articles.
1. Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.
2. Available from: https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html . Accessed on 3/15/2018.
3. • Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30–66. This article describes the common links between breast cancer and cardiovascular disease and discusses ways to address common risk factors and guidelines for surveillance and prevention of cardiotoxicity in breast cancer patients.
4. Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981–8.
5. Geisberg CA, Sawyer DB. Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage. Curr Hypertens Rep. 2010;12(6):404–10.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer;International Journal of Molecular Sciences;2024-09-09
2. The clinical manifestations and molecular pathogenesis of radiation fibrosis;eBioMedicine;2024-05
3. Kanserli Olgularda Kardiyak Rehabilitasyon Perspektifi;İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi;2024-04-30
4. The Way Out From the Labyrinth of Anticancer Therapies for Patients with Breast Cancer: How Can We Improve Their Cardiac Safety and Quality of Life?;The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach;2023-12-18
5. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions;European Journal of Clinical Pharmacology;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3